CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Current assets
Cash and cash equivalents, $2,042 reserved at December 31, 2013	$ 6,258	$ 10,205
Other current assets	233	383
Total current assets	6,491	10,588
Patent license rights, net	823	980
Furniture and equipment, net	3	23
Total assets	7,317	11,591
Current liabilities
Accounts payable	88	233
Other accrued liabilities	12	61
Total current liabilities	100	294
Equity
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares in 2013 and 2012	20	20
Additional paid-in capital	189,215	189,181
Accumulated deficit ($154,256 at December 31, 2013 and $150,335 at December 31, 2012, accumulated during development stage period)	(182,018)	(178,097)
Total Capstone Therapeutics Corp. stockholders' equity	7,217	11,104
Noncontrolling interest	0	193
Total equity	7,217	11,297
Total liabilities and equity	$ 7,317	$ 11,591